Structural variation (SV), BioNano’s area of specialization, is more than a next generation of gene sequencing; it’s taking the field in a different direction altogether.

SAN DIEGO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by the Human Genome Stru ...

SAN DIEGO, April 17, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ...

Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for-60 reverse stock split that will take effect on Friday at 5 p.m. In a ...

SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant upgrades to its suite of computational tools for comprehensive cancer analysis. These ...

By using Genoox technology for aligning short read sequence data to Bionano’s SV calls, the high sensitivity of Bionano calls will be combined with the basepair precision of NGS. The ...

The Bionano Genomics, Inc. stock price is volatile and spiked to an all-time high of $14 in early 2021, and $3.6 as recently as August - offering very attractive upside potential - but after ...

According to InvestingPro data, Bionano Genomics has a market capitalization of $53.57 million and has experienced significant revenue growth of 26.93% over the last twelve months as of Q1 2024.

Illumina (ILMN 0.67%) and Bionano Genomics (BNGO-0.30%) might both make gene sequencing devices, but as investments the two couldn't be more different. Whereas Bionano is a new entrant to the ...

The latest analysis pipeline, Bionano Solve 3.8.1, enhances the sensitivity and specificity for structural variation (SV) detection from OGM data, which, when combined with copy number variant ...